Mechanism of osteoclastogenesis inhibitory action by interleukin 18

白细胞介素18抑制破骨细胞生成的机制

• 批准号: 09671905
• 负责人: UDAGAWA Nobuyuki
• 金额: $ 2.3万
• 依托单位: Showa University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (C)
• 财政年份: 1997
• 资助国家: 日本
• 起止时间: 1997 至 1998
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-09671905/
• 关键词: Osteoclast; Osteoblast; Bone resorption; Interleukin 18; Interferon gamma; GM-CSF; T-lymphocyte; Gene targetting mouse

IL-18 inhibits osteoclast (CCL) formation in vitro independent of IFN-gamma production, and this was abolished by the addition of neutralizing antibodies to GM-CSF.We now establish that IL-18 was unable to inhibit CCL formation in cocultures using GM-CSF-deficient mice (GM-CSF-/-). Reciprocal cocultures using either wild-type osteoblasts with GM-CSF -/- spleen cells or GM-CSF -/- osteoblasts with wild-type spleen cells were examined. Wild-type spleen cells were required to elicit a response to IL-18 indicating that cells of splenic origin were the IL-18 target. As T cells comprise a large proportion of the spleen cell population, the role of T cells in osteoclastogenesis was examined. Total T cells were removed and repleted in various combinations. Addition of wild-type T cells to a GM-CSF -/- coculture restored IL-18 inhibition of osteoclastogenesis. Major subsets of T cells, 0D4 and CD8+^+, were also individually depleted. Addition of either CD4^+ or CD8^+ wild-type T cells restored IL-18 action in a GM-CSF -/- background, while IL-18 was ineffective when either CD4^+ or CD8^+ GM-CSF -/- T cells were added to a wild-type coculture. These results highlight the involvement of T cells in IL-18-induced CCL inhibition and provide evidence for a new CCL inhibitory pathway whereby IL-18 inhibits CCL formation due to action upon T cells promoting the release of GM-CSF, which in turn acts upon CCL precursors.

IL-18在体外抑制破骨细胞（CCL）的形成，而不依赖于IFN-γ的产生，这一点可通过加入GM-CSF的中和抗体来消除。检查了使用野生型成骨细胞与GM-CSF -/-脾细胞或GM-CSF -/-成骨细胞与野生型脾细胞的相互共培养物。需要野生型脾细胞来引发对IL-18的应答，表明脾来源的细胞是IL-18靶标。由于T细胞在脾细胞群中占很大比例，因此检查了T细胞在破骨细胞生成中的作用。取出总T细胞并以各种组合补充。在GM-CSF -/-共培养物中加入野生型T细胞恢复了IL-18对破骨细胞生成的抑制作用。T细胞的主要亚群，CD 4和CD 8 +^+，也被单独耗尽。加入CD 4 ^+或CD 8 ^+野生型T细胞可以恢复IL-18在GM-CSF -/-背景下的作用，而当加入CD 4 ^+或CD 8 ^+ GM-CSF -/- T细胞到野生型共培养物中时，IL-18则无效。这些结果突出了T细胞参与IL-18诱导的CCL抑制，并为新的CCL抑制途径提供了证据，其中IL-18抑制CCL形成，这是由于对T细胞的作用促进了GM-CSF的释放，GM-CSF又作用于CCL前体。

项目成果

Katayama,Y.,et al.: "Casein kinase 2 phosphorylation of recombinant rat osteopontin enhances adhesion of osteoclasts but not osteoblasts." J.Cell.Physiol.176. 179-187 (1998)

Katayama, Y., et al.：“重组大鼠骨桥蛋白的酪蛋白激酶 2 磷酸化可增强破骨细胞的粘附，但不会增强成骨细胞的粘附。”

Nakamura,I.,et al.: "Lack of vacuolar proton ATPase association with the cytoskeleton in osteoclasts of osteosclerotic (oc/oc) mice." FEBS Lett.401. 207-212 (1997)

Nakamura,I.,et al.：“骨硬化 (oc/oc) 小鼠破骨细胞中缺乏与细胞骨架相关的液泡质子 ATP 酶。”

Udagawa, N., et al.: "Interleukin-18(interfero-γ-inducing factor)is produced by osteoblasts and acts via granulocyte/macrophage-colony stimulating factor and not via interferon-γ to inhibit osteoclast formation." J.Exp.Med.185. 1005-1012 (1997)

Udakawa, N. 等人：“Interleukin-18（干扰素 γ 诱导因子）由成骨细胞产生，通过粒细胞/巨噬细胞集落刺激因子而不是干扰素 γ 抑制破骨细胞形成。” .医学185.1005-1012（1997）

Tsurukai,T.,et al.: "Isolation and characterization of osteoclast precursors that differentiate into osteoclasts on calvarial cells within a short period of time." J.Cell.Physiol.177. 26-35 (1998)

Tsurukai,T.,et al.：“破骨细胞前体的分离和表征，这些前体在短时间内在颅骨细胞上分化为破骨细胞。”

Matsuzaki, K., et al.: "Osteoclast differentiation factor(ODF)induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures." Biochem.Biophys.Res.Commun.246. 199-204 (1998)

Matsuzaki, K. 等人：“破骨细胞分化因子 (ODF) 在人外周血单核细胞培养物中诱导破骨细胞样细胞形成。”